Back to Search
Start Over
Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients
- Source :
- Haematologica 3 (101), E86-E90. (2016), Haematologica, Haematologica, Ferrata Storti Foundation, 2016, 101 (3), pp.e86-90. ⟨10.3324/haematol.2015.135103⟩
- Publication Year :
- 2015
-
Abstract
- Fossard, Gaelle Blond, Emilie Balsat, Marie Morisset, Stephane Giraudier, Stephane Escoffre-Barbe, Martine Labussiere-Wallet, Helene Heiblig, Mael Bert, Arthur Etienne, Madeleine Drai, Jocelyne Sobh, Mohamad Redonnet-Vernhet, Isabelle Lega, Jean-Christophe Mahon, Francois-Xavier Etienne, Gabriel Nicolini, Franck Emmanuel; International audience
- Subjects :
- Male
Myeloid
Homocysteine
[SDV]Life Sciences [q-bio]
Coronary Artery Disease
Pharmacology
Gastroenterology
Tyrosine-kinase inhibitor
chemistry.chemical_compound
0302 clinical medicine
infection chronique
hemic and lymphatic diseases
Prospective Studies
BCR-ABL
ComputingMilieux_MISCELLANEOUS
Age Factors
Hematology
Middle Aged
erythroleucémie
chronic phase CML
nilotinib
homocysteine
cardiovascular events
3. Good health
Leukemia
medicine.anatomical_structure
030220 oncology & carcinogenesis
Leukemia, Myeloid, Chronic-Phase
Imatinib Mesylate
Female
patient
medicine.drug
Adult
Hyperhomocysteinemia
medicine.medical_specialty
Adolescent
medicine.drug_class
Antineoplastic Agents
Chronic phase chronic myelogenous leukemia
Drug Administration Schedule
03 medical and health sciences
Internal medicine
medicine
Humans
Online Only Articles
Triglycerides
Aged
Retrospective Studies
business.industry
Cholesterol, HDL
medicine.disease
Imatinib mesylate
Pyrimidines
chemistry
Nilotinib
cardiovasculaire
business
Hématologie
thérapie
030215 immunology
Subjects
Details
- ISSN :
- 15928721 and 03906078
- Volume :
- 101
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Haematologica
- Accession number :
- edsair.doi.dedup.....44f05ab27b1cb6063a3448d7d56b4176